# FOSAPREPITANT DIMEGLUMINE
> **ANDA204845** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS · Approved 2017-03-28
## Drug
- **FDA Application Number:** ANDA204845
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** Fosaprepitant Dimeglumine
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** UNKNOWN
- **Route:** UNKNOWN
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SAGENT PHARMS
- **First approval:** 2017-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204845)
---
*MORVS · CC0 1.0*